Brazil primary care plans sets new equipment standards
This article was originally published in Clinica
Brazil has approved a root-and-branch reform of its national primary care system, featuring further decentralisation, backed by new standards of equipment provision, minimum population coverage levels and a new (operational) financing regime.
You may also be interested in...
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.
Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.